🇯🇵 Novolog in Japan

PMDA authorised Novolog on 20 September 2019

Marketing authorisation

PMDA — authorised 20 September 2019

  • Marketing authorisation holder: Novo Nordisk Pharma Ltd.
  • Status: approved

Novolog in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Novolog approved in Japan?

Yes. PMDA authorised it on 20 September 2019.

Who is the marketing authorisation holder for Novolog in Japan?

Novo Nordisk Pharma Ltd. holds the Japanese marketing authorisation.